Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator

Similar documents
MARY JANE ON CAMPUS? EMPLOYEE AND STUDENT USE OF MEDICAL MARIJUANA APPLICABLE LAWS CONTROLLED SUBSTANCES ACT

New Mexico. Prescribing and Dispensing Profile. Research current through November 2015.

I MINA' TRENTI DOS NA LIHESLATURAN GUAHAN 2013 (FIRST) Regular Session

LEGAL ASPECTS of MEDICAL MARIJUANA Florida Nurse Practitioner Network Annual Conference September 17, 2018

Weeding Through the Workplace Impact of Medical Marijuana

Maine s Medical Marijuana Law. 40 th Annual ASMAC Fall Conference Ritz Carlton Lake Tahoe October 26, 2014

Policy \ \ Medical (Palliative) Use of Marijuana

Policy / Drug and Alcohol-Free Workshops

ASA Model Legislation (updated July 2014)

Smoke and Mirrors: Navigating Medical Marijuana in the Workplace

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Compassionate Medical Cannabis: What It Means to the Street Officer

Medical Marijuana Update Chris Belletieri, DO

Medical Cannabis Ordinances. Tuesday, December 20, 2016

Pennsylvania s Medical Marijuana Act and the Creation of a New Protected Class of Employees. Agenda

Medical Marijuana Update

Diane E. Hoffmann, J.D., M.S. University of Maryland School of Law

MEDICAL MARIJUANA USE

Be it enacted by the People of the State of Illinois,

New York. Prescribing and Dispensing Profile. Research current through November 2015.

SONOMA COUNTY LAW ENFORCEMENT CHIEFS ASSOCIATION

Insight. Marijuana Legalization Efforts Enjoy Success, Demonstrating Major Shift in Approach to Drug Regulation and Use NOVEMBER 9, 2016

Coordinated Student Health Services. Medical Marijuana/ Low THC Cannabis Use To Qualified Students In Schools Policy

The Legalization of Medical Marijuana and the Impact on the Workplace

OREGON MEDICAL MARIJUANA ACT

ASSEMBLY APPROPRIATIONS COMMITTEE STATEMENT TO. ASSEMBLY COMMITTEE SUBSTITUTE FOR ASSEMBLY, No STATE OF NEW JERSEY DATED: APRIL 5, 2018

Question 2 made some recreational marijuana legal under Nevada state law.

Understanding Maine s Medical Marijuana Law

Medical Cannabis MATT WEBSTER DO, MS

Minnesota Medical Cannabis Program. October 24, 2017

CERTIFICATION OF ENROLLMENT ENGROSSED SUBSTITUTE SENATE BILL th Legislature 2007 Regular Session

THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL

SECTION V: EMPLOYEES POLICY 5375 MEDICAL MARIJUANA, HEMP & CANNABIDIOL (CBD)

128th MAINE LEGISLATURE

MEDICAL CANNABIS IN MINNESOTA

ARIZONA MEDICAL MARIJUANA PROGRAM. Tina Wesoloskie, MPA Office of Medical Marijuana Card Registry Arizona Department of Health Services

Table of Contents. Overview 3 Eligibility 3

AZ s Medical Marijuana Law Overview and Considerations. Ryan Hurley Partner, Chair of MMJ Dept. Rose Law Group pc

Frequently Asked Questions

MEDICAL CANNABIS IN MINNESOTA

HEALTH WELLNESS COMMUNITY

Marijuana: Laws Allowing the Limited Use of Low-THC Oil for Medicinal Purposes

Substitute HB 523 Outline

MINNESOTA S MEDICAL CANNABIS PROGRAM

To the Reader. Mahalo. Second Edition

78th OREGON LEGISLATIVE ASSEMBLY Regular Session. Senate Bill 964 SUMMARY

Minnesota. Prescribing and Dispensing Profile. Research current through November 2015.

Scottsdale Certification Center Health History Questionnaire. Name Gender M / F Date. Date of Birth / / Phone Ht: ft in Wt. Residential Address

From heroin to medical marijuana: what districts need to know Megan Greulich, Staff Attorney Hot Topics in School Law October 5, 2016

Workplace Issues Associated with Legalized Marijuana. James B. Yates, Esq., SHRM-SCP, SPHR

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD

Ohio s Medical Marijuana Control Program

HOUSE BILL NO Representatives P. Anderson, Glassheim, Hawken, Maragos, M. Nelson, Schneider, Strinden

Navigating the Rapidly Changing World of Marijuana and the Workplace. January 16, 2018

A Snapshot: Medical Marijuana in Rural New Mexico & Benefits of Legalizing Adult Use of Marijuana in Rural New Mexico

ENROLLED 2014 Legislature CS for CS for SB 1030, 1st Engrossed

TEXAS COMPASSIONATE-USE ACT

MEDICAL MARIJUANA AND HEALTH CARE FACILITIES

MEMORANDUM. DATE: November 19, Senator Kohl-Welles. Kathleen Buchli, Counsel medical marijuana proposal

Life s brighter under the sun MEDICAL CANNABIS AND GROUP BENEFITS PLAN COVERAGE

Allegiance Wellness Center

Membership Package Checklist

What Cities Need to Know about the Arkansas Medical Marijuana Amendment ( AMMA ) 1

North Central Florida Regional Planning Council

CHAPTER Committee Substitute for Committee Substitute for Senate Bill No. 1030

Senate File Introduced

In New York State. Highly Worth It OR Not??? Medical Marijuana. The Truths 3/29/2018. True or False???

City of Coral Gables Planning and Zoning Staff Recommendation

This questionnaire will ask you about approved medical use of extracts and tinctures of cannabis at national level.

(b) It consists, in whole or in part, of any filthy, putrid, or decomposed substance, including mold, mildew, and other contaminants;

Senator Mark B. Madsen proposes the following substitute bill:

The Department must establish a minimum of three regions within the state for the purpose of granting permits to growers/processors and dispensaries.

1 SB By Senator Sanford. 4 RFD: Judiciary. 5 First Read: 14-JAN-14. Page 0

Medical Marijuana Consent Form

AGENDA. 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up

416 DRUG AND ALCOHOL TESTING I. PURPOSE

California. Prescribing and Dispensing Profile. Research current through November 2015.

HR UP IN SMOKE: THE INTERSECTION BETWEEN MARIJUANA LEGALIZATION AND EMPLOYMENT LAW. Michigan Municipal League

CANADIAN CANNABIS CRAZE (AND CONUNDRUM) Dr. Melissa Snider-Adler Chief Medical Review Officer DriverCheck Inc. Addiction Medicine Physician

Questionnaire 1 of 5: Cannabis Plant and Cannabis Resin. Introduction

An HR Perspective: Medical Marijuana and How it Affects Employers

PATIENT QUESTIONNAIRE

Act 16 and Medical Cannabis in Pennsylvania

MEDICAL MARIJUANA/LOW THC CANNABIS USE TO QUALIFIED STUDENTS IN SCHOOLS

Medical Marijuana and Student Health. New England College Health Association Gordon H. Smith, Esq. October 30, 2014

MEMORANDUM INTRODUCTION. DATE: July 28, 2016; Revised August 3, 2016 TO:

How High? Insurance and Medical Marijuana in 2017

8/31/2016. Workplace Implications of Marijuana in the US. Goal

AN ORDINANCE OF THE BOARD OF COUNTY

AN ACT IN THE COUNCIL OF THE DISTRICT OF COLUMBIA

Medicinal cannabis. What is medicinal cannabis? What are cannabinoids? The endocannabinoid system

The West Virginia Medical Cannabis Act

Marijuana in the Workplace: The 411 on 420

the natural choice Page 1

F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HJR

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017

Agracan - LP. Palmerston Industrial Park Cannabis Cultivation Facility

77th OREGON LEGISLATIVE ASSEMBLY Regular Session. Enrolled. House Bill 3460

Transcription:

Medical Cannabis Program Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator

Disclaimer The following information is based upon research of current studies. The Department of Health is providing the research for information purposes only. The following are not recommendations by the department of health, rather information as to how cannabis MAY affect a person.

Presentation layout Introductions Andrea Purpose of the program/brief history Dr. Small- Medical Cannabis Science Andrea-NM Program and enrollment Questions and Answers Closing

Purpose of the Program The Lynn and Erin Compassionate Use Act (CUA): The purpose of the act is to allow the beneficial use of medical cannabis in a regulated system for alleviating symptoms caused by debilitating medical conditions and their medical treatments

History of Cannabis Cannabis plant and its uses date to as early as 4000 BC Long recorded history in medical writing Rendered illegal in 1937 Dropped from the US Pharmacopeia in 1941 1970 U. S. Controlled Substances Act Classifies Marijuana as a Drug with "No Accepted Medical Use Nov. 24, 1976 - Federal Court Rules Robert Randall's Use of Marijuana a "Medical Necessity 1978-New Mexico Passes First State Law Recognizing Medical Value of Marijuana Mar. 13, 2007 - New Mexico Becomes 12th State to Legalize Medical Marijuana

Endocannabinoids Natural substances produced by the body Bind to receptors throughout the body Exogenous cannabis plant has > 60 cannabinoids CB1 Receptors CB2 Receptors

Brain (CB1) GI Tract (CB2 and CB1) Adipocyctes (CB1) Endocannabinoid System Peripheral Nerves (CB1) Liver (CB1 and CB2) Skeletal Muscle Immune System (CB2)

Endocannabinoids Anandamide and 2AG 1. Synaptic moderators move both ways at synapse unlike Dopamine 2. May be involved in Runners High

Risks and Benefits Researched Risks of Cannabis Use: Risks of smoking product Cardiovascular issues General effects to the body Neuropsychiatric Researched Benefits of Cannabis Use: Appetite stimulation Antiemetic Antispasmodics Analgesic

CBD vs. THC CBD and THC are two of the main chemicals in cannabis effecting symptoms. CBD (Cannabidiol) Sedative and analgesic, pain-reducer, antiemetic, anti-anxiety *CBD lessens the side effect of THC THC (delta-9-tetra hydrocannabinol) Euphoric, stimulant, muscle-relaxing, analgesic, anti-emetic, appetite stimulating, antidepressant qualities. The chemical that makes you high A high CBD is 5-15% A High THC is 15-25%

Ingestion options Please see handout for more detailed information regarding ingestion options Smoke Vaporize Edible Tincture Topical Tea/soda Hash/wax

NM Medical Cannabis Program Types of cards Patient Card Primary Caregiver Card Producer ID Card Licensed Non-Profit Producer Card

Qualifying Conditions Cancer Glaucoma HIV/AIDS Multiple Sclerosis Epilepsy Spinal Cord Damage with Intractable Spasticity Painful peripheral neuropathy * Intractable nausea/vomiting Severe anorexia/cachexia Huntington's Parkinson s Hepatitis C infection currently receiving antiviral treatment Chrohn s disease Post-traumatic Stress Disorder * Amyotrophic Lateral Sclerosis Inflammatory autoimmune mediated arthritis Spasmodic Torticollis (Cervical dystonia) Severe Chronic pain * Any patient in hospice care

Patient Application Requirements Consent to Release Medical Information Valid NM Drivers license or ID confirming New Mexico residency Medical Provider Certification Diagnosis of the Medical Condition Provider Information Certification Condition is debilitating Standard treatments have failed to bring adequate relief Potential risks & benefits have been discussed with patient.

Protection to Medical Providers A practitioner shall not be subject to arrest or prosecution, penalized in any manner or denied any right or privilege for recommending the medical use of cannabis or providing written certification for the medical use of cannabis pursuant to the Lynn and Erin Compassionate Use Act. The Department must keep the names of practitioners who sign the certification confidential.

Application Requirements Some qualifying conditions have additional requirements Severe Chronic Pain Requires a second certification from a medical specialist with expert knowledge of either pain management or of the condition that is causing the Severe Chronic Pain PTSD Must have annual medical records or documentation from a Psychiatrist or Psychiatric Nurse Practitioner confirming the diagnosis and that diagnosis meets the requirements under DSM 309.81 for PTSD. Painful Peripheral Neuropathy Medical records must be sent to document of objective evidence of neuropathy Inflammatory autoimmune mediated arthritis Rheumatologist certification required

Additional Application Requirements Depending on the case, applicants are sometimes asked to submit additional medical records. Records may be requested in order to verify prior treatments, confirm debilitating condition, etc.

Review Process Within 30 days: Program staff will verify that all required documents are present. If documents are missing, staff will either send a letter or contact the applicant. Medical Director reviews/approves application Verifies provider s authority to certify If needed, calls certifying provider for verification of the patient s medical condition, history, time in care, etc. Confirms that the certifying medical provider believes that the benefits of medical cannabis usage outweigh the risks for the applicant. If denied, a formal notice is mailed to the patient. If approved, the patient will receive; Patients registry I.D. Card Contact information for licensed non-profit producers. Basic Do s and Do Not's of the Program

Yearly Renewal Pursuant to statute Patient enrollments expire 1 year from the date of enrollment printed on their registry ID card Patient personal production licenses expire at the same time the patient s annual enrollment expires, whichever is sooner.

What Enrollment Provides Under Compassionate Use Act Patients receive: Legal protection to possess an adequate supply which is defined in regulation as a supply of up to 6 ounces over a three month period. The right to purchase from Licensed Non-Profit Producers. The right to be is possession of any paraphernalia used in connection with their use of medical cannabis. A patient or primary caregiver shall be granted full legal protection if they are in possession of their medical cannabis card. If they are not in possession of their card they shall be given time to produce the card before any arrest or criminal charges (Lynn and Erin Compassionate Use Act Section 4 (D))

Patient Limitation The statute states: Participation in a medical use of cannabis program by a qualified patient or primary caregiver does not relieve the qualified patient or primary caregiver from: (1) criminal prosecution or civil penalties for activities not authorized in the Lynn and Erin Compassionate Use Act; (2) liability for damages or criminal prosecution arising out of the operation of a vehicle while under the influence of cannabis; or (3) criminal prosecution or civil penalty for possession or use of cannabis: (a) in a school bus or public vehicle; (b) on school grounds or property; (c) in the workplace of the qualified patient's or primary caregiver's employment; or (d) at a public park, recreation center, youth center or other public place.

No Legal Protection In a school bus or public vehicle; On school grounds or property; In the workplace of the qualified patient's or primary caregiver's employment At a public park, recreation center, youth center or other public place; To a person not approved by the department pursuant to this rule; Outside New Mexico or attempts to obtain or transport cannabis from outside New Mexico; or That exceeds the allotted amount of useable medical cannabis.

What Enrollment Does Not Provide Protection regarding patient sales Employment and Housing Protection Patients must follow all other laws (DUI, Use in front of children, etc.)

Will the federal government come after me? U.S. Dept of Justice Memorandum Oct. 19, 2009 Subject: Investigations and Prosecutions in States Authorizing the Medical Use of Marijuana As a general matter, pursuit of there priorities should not focus federal resources in your States on individuals whose actions are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana. For example, prosecution of individual with cancer or other serious illnesses who use marijuana as part of a recommended treatment regimen consistent with applicable state law, or those caregivers in clear and unambiguous compliance with existing state law who provide such individuals with marijuana, is unlikely to be an efficient use of limited federal resources.

Supply Options Purchase through a Licensed Non-Profit Producer Upon acceptance into the Program, patients are provided with contact information for licensed nonprofit producers. Non-profit producers are businesses that have been granted a production license from the Department of Health. Purchase of product is an individual transaction between the qualified patient and producer Producers information is confidential.

Supply Options Personal Production License Patients enrolled in the medical cannabis program may apply for a personal production license Grants permission to grow 4 mature ( i.e. flowering) cannabis plants and 12 seedlings (i.e. non-flowering) at any given time Non-refundable $30 fee waived with proof of income < 200% of Federal Poverty Guidelines

What the program can provide Information on locations and people if conducting an investigation Confirmation of status in the program 24 Hour Law Enforcement Number 505-231-6740

Questions and Answers

For More Information Website: nmhealth.org divisions-mcp Phone: (505) 827-2321 Email: medical.cannabis@state.nm.us 24 Hour Law Enforcement Number 505-231-6740